William Mann
Nessuna posizione attualmente
Profilo
William R.
Mann is the founder of Lodestar Biopharma Solutions LLC (founded in 2018) and ArtLifting PBC (founded in 2013).
At ArtLifting PBC, he held the title of Chief Executive Officer.
Dr. Mann's former positions include President & Director at Helsinn Therapeutics (U.S.), Inc. (2006-2018), Vice President-Corporate Development at Sapphire Therapeutics, Inc., and Principal at Novartis Corp.
He also briefly held the position of President & Chief Operating Officer at NeuBase Therapeutics, Inc. in 2022.
Dr. Mann holds a doctorate from the University of Aberdeen and an MBA from Rutgers State University of New Jersey.
Precedenti posizioni note di William Mann
| Società | Posizione | Fine |
|---|---|---|
| NEUBASE THERAPEUTICS, INC. | Presidente | 31/10/2022 |
Helsinn Therapeutics (U.S.), Inc.
 Helsinn Therapeutics (U.S.), Inc. Pharmaceuticals: MajorHealth Technology Helsinn Therapeutics (U.S.), Inc. develops, manufactures and supplies pharmaceutical products for treatment of cancer. The company is headquartered in Iselin. NJ. | Amministratore Delegato | 01/02/2018 |
ArtLifting PBC
 ArtLifting PBC Miscellaneous Commercial ServicesCommercial Services ArtLifting PBC operates online marketplace that sells the artwork of homeless and disabled artists. Its marketplace sells prints, originals, phone cases, gift cards, and other cards. The company was founded by Liz Powers and Spencer Powers and is headquartered in Boston, MA. | Amministratore Delegato | - |
| Lodestar Biopharma Solutions LLC | Fondatore | - |
Novartis Corp.
 Novartis Corp. Pharmaceuticals: MajorHealth Technology Novartis Corp. manufactures pharmaceuticals, vaccines, consumer health, generics, eye care and animal health products. It manufactures drugs for oncology, hypertension, diabetes, cancer and cardiovascular diseases. The company was founded on November 15, 1996 and is headquartered in New York, NY. | Corporate Officer/Principal | - |
Formazione di William Mann
| University of Aberdeen | Doctorate Degree |
| Rutgers State University of New Jersey | Masters Business Admin |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 6 |
|---|---|
Sapphire Therapeutics, Inc.
 Sapphire Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Sapphire Therapeutics, Inc. develops biopharmaceutical products. It develops compounds for the treatment of oncologic and metabolic diseases. The firm products include anamorelin for the treatment of anorexia and cachexia. The company was founded in 2000 and is headquartered in Bridgewater, NJ. | Health Technology |
Novartis Corp.
Novartis Corp. Pharmaceuticals: MajorHealth Technology Novartis Corp. manufactures pharmaceuticals, vaccines, consumer health, generics, eye care and animal health products. It manufactures drugs for oncology, hypertension, diabetes, cancer and cardiovascular diseases. The company was founded on November 15, 1996 and is headquartered in New York, NY. | Health Technology |
Helsinn Therapeutics (U.S.), Inc.
Helsinn Therapeutics (U.S.), Inc. Pharmaceuticals: MajorHealth Technology Helsinn Therapeutics (U.S.), Inc. develops, manufactures and supplies pharmaceutical products for treatment of cancer. The company is headquartered in Iselin. NJ. | Health Technology |
ArtLifting PBC
ArtLifting PBC Miscellaneous Commercial ServicesCommercial Services ArtLifting PBC operates online marketplace that sells the artwork of homeless and disabled artists. Its marketplace sells prints, originals, phone cases, gift cards, and other cards. The company was founded by Liz Powers and Spencer Powers and is headquartered in Boston, MA. | Commercial Services |
NeuBase Therapeutics, Inc.
 NeuBase Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology NeuBase Therapeutics, Inc. is a biotechnology company, which engages in the development of drugs for patients with genetic neurological disorders. The firm’s therapies are built on a proprietary platform called PATrOL that encompasses a novel peptide-nucleic acid antisense oligonucleotide technology combined with novel delivery shuttles that overcome many of the hurdles to selective mutation engagement, repeat dosing, and systemic delivery of genetic medicines. The company was founded by Dietrich A. Stephan on March 29, 2002 and is headquartered in Pittsburgh, PA. | Health Technology |
| Lodestar Biopharma Solutions LLC |
- Borsa valori
- Insiders
- William Mann
